Skip to Main Content
An official website of the United States government

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
921-940 of 1488
Name Principal Investigator Institution Study Date Approved Project ID
Genome-wide association analysis of genetic variants and prostate cancer risk and prognosis Qingyi Wei Duke Cancer Institute PLCO Dec 22, 2014 PLCO-124
Retrieval of HPV-driven tumors for HPV analysis Aimee Kreimer NIH PLCO Dec 16, 2014 PLCO-123
The Influence of Self-Reported Finasteride Use on the Incidence of Renal Cancer Michael Liss University of Texas Health Science Center San Antonio PLCO Dec 16, 2014 PLCO-120
Lung Cancer Risk by Time Since Quit Smoking Paul Pinsky NCI PLCO Dec 15, 2014 PLCO-122
Medication use in older people: a study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening cohort (PLCO) Amanda Black NCI/DCEG PLCO Dec 11, 2014 PLCO-121
Metabolomic profiling for pancreatic cancer risk in the PLCO Cancer Screening Trial Amrita Cheema Georgetown University PLCO Nov 25, 2014 PLCO-119
Influence of circulating testosterone concentrations on the relationship between 25(OH)D and prostate cancer Stephanie Weinstein NCI PLCO Nov 19, 2014 PLCO-113
Validation of breast cancer risk models in PLCO Montserrat Garcia-Closas NCI/DCEG PLCO Nov 14, 2014 PLCO-116
Causal Inference for Prostate Cancer Screening and Treatment using a Bayesian Hierarchical Latent Class Approach Rebecca Y Coley Johns Hopkins Bloomberg School of Public Health PLCO Nov 12, 2014 PLCO-118
Cause of death in the NLST and PLCO: comparison of death certificates and endpoint adjudication Pamela Marcus NCI PLCO Nov 10, 2014 PLCO-117
Type 1 and Type 2 ovarian cancer in the PLCO Trial Keith Terada University of Hawaii PLCO Nov 4, 2014 PLCO-115
Study of racial disparities in colorectal cancer screening using flexible sigmoidoscopy and cancer outcomes: An analysis of the PLCO Cancer screening trial. Sejong Bae UAB PLCO Oct 29, 2014 PLCO-112
An Econometric Evaluation of Prostate Cancer Treatments Michael Grossman CUNY and NBER PLCO Oct 20, 2014 PLCO-108
Identifying Optimal Cohort for Renal Cell Cancer Screening Yair Lotan University of Texas Southwestern PLCO Oct 9, 2014 PLCO-109
Genome-Wide Predictors of Survival in Colorectal Cancer Polly Newcomb Fred Hutchinson Cancer Center PLCO Oct 7, 2014 PLCO-101
A Comparative Cost-Effectiveness Analysis of Lung Cancer Screening by CT and Chest X-ray Gary Strauss Tufts Medical Center PLCO Oct 2, 2014 PLCO-107
The Association of 5 Alpha Reductase Inhibitor Use and the Natural History of Bladder Cancer Michael Liss University of Texas Health Science Center San Antonio PLCO Oct 2, 2014 PLCO-110
Examining the Relationships between Physical Activity Variables and Cancer Screening and Risk in the PLCO Trial Rebecca Simmons University of Utah PLCO Sep 9, 2014 PLCO-106
Pre-diagnostic obesity, smoking and lymph node involvement at breast cancer diagnosis. Ian Barron Johns Hopkins PLCO Sep 9, 2014 PLCO-99
HFHS Electronic Medical Records compared to HFHS PLCO data Melody Eide Henry Ford Health System PLCO Sep 9, 2014 PLCO-105